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Nursing Implications 
Marfan Syndrome in Athletes 
Chelsey Hastings, RN, BSN, CCRN 
Introduction 
 
Presentation of the Case 
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Lamar has played 
basketball his entire life. His 
height, long arms, and long 
fingers have propelled him to 
the top of every team and 
league he has ever 
participated in. Lamar is 6’8”, 
has bilateral lens 
discoloration, and slight 
scoliosis of the spine. As a 
child he also had a detached 
retina, which required repair. 
Lamar has to have an 
echocardiogram done as part 
of his yearly physical to play 
division one basketball.  
After the screening, he is 
referred to a cardiologist 
because the test reveals a 
dilated aortic root. Genetic 
testing reveals a mutation in 
the gene FBN1, found on 
chromosome 15. These factors 
as scored by the Ghent 
Criteria, are enough to 
diagnose Lamar with Marfan 
syndrome. The phenotype of 
Marfan syndrome can be very 
variable (Braverman, 2015). 
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Significance of Pathophysiology 
When diagnosed, Marfan patients can have a normal life 
expectancy with crucial lifestyle modifications in place. 
Undiagnosed, Marfan syndrome can unfortunately lead to an early, 
unexpected death. The APN has a responsibility to inform 
themselves on the symptoms expressed by this rare disease. 
Becoming a knowledgeable APN can benefit the young athletes in 
their community. 
Conclusion  
 
 
 
 
 
The most crucial step for the 
advanced practice nurse (APN) 
in dealing with Marfan syndrome 
is the diagnosis. Becoming 
familiar with the Ghent criteria 
can help the APN recognize the 
signs of Marfan in the general 
public and athletes in particular. 
The Ghent nosology involve a 
scoring system where systemic 
features of Marfans are graded 
(Wright & Connolly, 2015). In 
athletes with Marfan-like 
qualities of superior height and 
extended extremity length, an 
echocardiogram should be 
performed. This test can give the 
APN a view of the heart using 
sound waves (Greenemeier, 
2014).  Gene testing can be 
performed, but is usually only 
done so in families that have a 
high occurrence of Marfan. Once 
the disease is diagnosed the APN 
can focus on the medical 
management of the disease with 
the patient. Physical activity 
should be modified in order to 
reduce the stress placed on the 
aorta (The Marfan Foundation, 
2015). Medications such as beta-
blockers or angiotensin receptor 
blockers are prescribed to lower 
the workload of the heart or 
aorta. The APN needs to stress to 
athletes and their families that 
this does not reduce the risk of 
strenuous exercise on the aorta. 
The APN must keep in mind the 
emotional toll that this may place 
on an athlete. Removing their 
ability to participate in 
strenuous sports such as 
basketball may result in 
depression. 
Genetic disorders are widely  
misunderstood in our society and can  
lead to early mortality. Marfan  
syndrome (MFS) is a genetic disorder 
that affects connective tissue  
(Harris, Croce, & Tian, 2014).  
Antoine Marfan, a French pediatrician,  
first described this disease in 1896  
(Elshershari & Harris, 2014).  
MFS can manifest in several different  
organ systems. The cardiovascular  
complications of aortic dilation 
and dissection often account for the  
morbidity  
associated with this disease  
(Harris et al., 2014). 
Understanding the inheritance,  
pathophysiology,  
and treatment of MFS is important for  
the advanced practice nurse (APN).  
Prevalence of the disease is  
approximately two per  
10,000 individuals, but it is thought  
that MFS is under diagnosed and  
authorities suspect 
MFS may affect one in 3,000  
(Pitcher, Emberson, Lacro, Sleeper,  
& Stylianou, 2015).  
MFS is most notable for affecting  
Abraham Lincoln and causing  
the death of Flo Hyman, a member of  
the 1986 US Olympian team  
(Davis, Dyar, Vargas, & Grossfeld,  
2015). By obtaining a detailed health  
history of all athletes and recognizing 
the rare phenotype expressed by  
children withMFS, the APN can  
prevent the mortality associated with  
MFS, especially in the athletic  
population. 
The underlying 
pathophysiology of Lamar’s 
diagnosis revolves around 
the  
alteration of the FBN1 gene. 
The disease is  
usually transmitted in an 
autosomal dominant fashion. 
FBN1 is responsible for  
encoding the glycoprotein 
fibrillin. Fibrillin is the 
structural component of  
microfibrils. Microfibrils 
serve as building blocks in 
the human body and 
ligaments  
found in eye lenses, the aorta, 
and other connective tissues 
(Chen, 2015). Defects in 
fibrillin cause weakness in 
these  
tissues and hence the 
abnormalities observed  
in patients with this disease. 
Transforming growth factor-
beta receptor (TGFBR) also  
plays an important role in 
Marfans. Fibrillin-1 binds to a 
form of TGFBR  
and keeps it sequestered 
throughout the body. 
Insufficient amounts of 
fibrillin cause an excess of 
TGFBR in the lungs, heart 
valves, 
and aorta. It is unclear how 
high levels  
of TGFBR cause the pathology 
associated  
with the disease.   
The significance of this pathophysiology explains the 
symptoms commonly seen. The defect in fibrillin coupled with 
the overabundance of TGFBR causes problems in connective 
tissue throughout the body (Greenemeir, 2014). In Lamar’s 
case, the dilated aortic root can lead to an emergent  
situation known as aortic dissection. This can be a life-
threatening emergency. Lamar suffered a retinal detachment as 
a young child because of Marfans, and the inability of the 
connective tissue of the eye to hold his retina in place 
 (Marfans Research Foundation, 2009). As people age and 
weaken with Marfan syndrome, the more likely they are to  
suffer consequences as connective tissue weakens as well. 
